1Lazzeroni E,Rolli A,Aurier E,et al.Clinical significance of coronary artery disease in hypertrophic cardiomyopathy.J Am J Cardiol,1992,70:499-501.
2Lardani H,Serrano JA,Villamil RJ.Hemodynamics and coronary angiography in idiopathic hypertrophic subaortic stenosis.Am J Cardiol,1978,41:476-481.
3Loogen F,Kuhn H,Gietzen F,et al.Clinical course and prognosis of patients with typical and atypical hypertrophic obstructive and hypertrophic non-obstructive cardimyopathy.Eur Heart J,1983,4(Suppl F):145-153.
4Kodama K,Hamada M,Kazatani Y,et al.Clinical characteristics in Japanese patients with coexistent hypertrophic cardiomyopathy and coronary vasospasm.Angiology,1998,49:849-855.
5Canon RO,Rosing DR,Maron BJ,et al.Myocardial ischemia in hypertrophic cardiomyopathy:contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures.Circulation,1985,71:234-243.
9Maron B J, McKenna WJ, Danielson GK, et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol, 2003, 42: 1687-1713.
10Knaapen P, Germans T, Camici PG, et al. Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol, 2008, 294: H986-H993.
